<div id="readability-page-1"><div><p>Health care stocks ended slightly lower with little fresh news to drive trading.</p><p>    Johnson &amp; Johnson said it closed its $3.05 billion acquisition of Halda Therapeutics, and that the deal is now expected to ding its adjusted earnings by 20 cents a share. Upon disclosing the deal last month, Johnson &amp; Johnson said it would reduce 2026 adjusted earnings by about 15 cents a share due to short-term financing and a charge related to equity awards for Halda employees. </p><p>   Write to Paulo Trevisani at paulo.trevisani@wsj.com </p><p>    (END) Dow Jones Newswires</p><p>12-29-25 1740ET</p></div></div>

<p>Healthcare stocks ended slightly lower amid light trading. Johnson & Johnson completed its $3.05 billion acquisition of Halda Therapeutics, which is expected to impact its adjusted earnings by 20 cents per share. Previously, the company anticipated a 15-cent reduction in 2026 adjusted earnings due to financing and equity awards for Halda employees.</p>

Healthcare Stocks Mixed in Light Trading -- Healthcare Roundup